271. Ankylosing spondylitis Clinical trials / Disease details


Clinical trials : 563 Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01789151
(ClinicalTrials.gov)
October 20127/2/201399m-Technetium- Glucosamine in Arthritis99mTc-labelled D-Glucosamine in the Evaluation of Disease Activity in Patients With Degenerative and Inflammatory Rheumatic ConditionsRheumatoid Arthritis;Ankylosing SpondylitisDevice: Technetium labelled glucosamineUniversity of SydneyAbbVieNo longer available18 Years90 YearsBothN/AAustralia